CNP 061
Alternative Names: CNP-061; GT-061Latest Information Update: 29 Jun 2005
Price :
$50 *
At a glance
- Originator Cita NeuroPharmaceuticals
- Class Hypnosedatives; Nootropics; Sleep disorder therapies
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Insomnia
Most Recent Events
- 21 Jun 2005 Discontinued - Preclinical for Insomnia in Canada (unspecified route)
- 02 Jun 2005 GB Therapeutics is now called Cita NeuroPharmaceuticals
- 28 Jun 2004 This compound is not in active development